Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL445001 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL29609979 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL30552890 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL483413 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL29397925 | 1.00 | UGT2B7 (1.00) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| Hydrochloric Acid SCHEMBL27389834 | 0.98 | UGT2B7 (0.96) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL10785006 | 0.93 | UGT2B7 (0.88) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL5610446 | 0.91 | UGT2B7 (0.82) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| Acetic Acid SCHEMBL7514323 | 0.90 | UGT2B7 (0.81) | UGT2B7MEN1KMT2AATMCYP2D6 | |
| SCHEMBL3151796 | 0.84 | UGT2B7 (0.73) | UGT2B7MEN1KMT2AATMCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800816-B | Green synthesis method of polysubstituted benzyl ether and polysubstituted benzaldehyde | 华东理工大学 | 2026-02-27 | — | — | CN | claimed |
| WO-2025053791-A1 | ONE-POT GRAFTING OF POLYMERS FROM ALCOHOLS AND BIOMASSES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-03-13 | — | — | WO | claimed |
| CN-118222171-A | Nanometer stamping adhesive for improving adhesive force of glass-based circuit and circuit manufacturing method based on glass substrate | 深圳市百柔新材料技术有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117720387-A | Synthesis method of 2-vinyl naphthalene | 江苏集萃光敏电子材料研究所有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-113035408-B | Solar cell grid line slurry and preparation method thereof, and solar cell | 深圳市百柔新材料技术有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-114057561-B | Application of perfluorosulfonic acid resin in catalyzing reaction of benzyl alcohol compound and 1, 3-dicarbonyl compound | 上海应用技术大学 | 2022-12-16 | — | — | CN | claimed |
| CN-110002961-B | Method for racemization-free synthesis of chiral alcohol | 三峡大学 | 2022-05-03 | — | — | CN | claimed |
| CN-111621031-B | Preparation method and application of mimic enzyme MOF-based chiral separation material | 合肥工业大学 | 2022-03-18 | — | — | CN | claimed |
| CN-112409845-A | Printing ink | TCL集团股份有限公司 | 2021-02-26 | — | — | CN | claimed |
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2020-12-10 | — | — | US | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| WO-2004111092-A1 | MODIFIED ALGINIC ACID OR ALGINIC ACID DERIVATIVES AND THERMOSETTING ANTI-REFLECTIVE COMPOSITIONS THEREOF | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2004-12-23 | — | — | WO | claimed |
| US-20040253532-A1 | Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof | MERCK PATENT GMBH (DE) | 2004-12-16 | — | — | US | claimed |
| EP-0950052-B1 | METHOD FOR PREPARING A TETRAHYDROPYRIDIN DERIVATIVE | SANOFI SYNTHELABO (FR) | 2004-09-08 | — | — | EP | claimed |
| US-6346194-B1 | SEPARATING RACEMIC MIXTURE BY CONTACTING WITH CHIRAL STATIONARY PHASE CONSISTING OF YOHIMBINE OR ANALOG THEREOF COVALENTLY BOUND TO REFRACTORY INORGANIC OXIDE CARRIER VIA SPACER | UOP LLC | 2002-02-12 | — | — | US | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | CPNE4, PPOX, PDCD5 | UGT2B7 3059/4885MEN1 472/4885KMT2A 927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.